Drug firm Ipca Laboratories Ltd on Wednesday (September 24) announced that it has signed a definitive technology transfer and joint development agreement with BioSimilar...
Global pharma major Lupin Ltd on Wednesday (September 24) said it has received tentative approval from the United States Food and Drug Administration (FDA)...
Marksans Pharma Ltd on Tuesday announced that its wholly owned UK subsidiary, Relonchem Limited, has received marketing authorisation from the UK Medicines and...
Lupin has bagged the approval for Lenalidomide capsules, the bioequivalent to Revlimid capsules manufactured by Bristol-Myers Squibb Company.This drug is used to treat...